Mobius Therapeutics
Manufacturing · Missouri, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1000 Executive Parkway Dr Ste 220, St. L...Phone Number
(314) 615-6930Website
www.mobiustherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Mobius Therapeutics
Mobius Therapeutics is an FDA-approved pharmaceutical manufacturer focused on perioperative pharmaceuticals specifically for ophthalmology. The company aims to lead in this niche by identifying challenging needs and innovating solutions to enhance patient care, access, and provider safety. Their product offerings can be easily ordered through various methods, including phone, fax, or online. Additionally, Mobius provides educational resources through its Perioperative Resource Center to support the ophthalmic community.Explore more
Mobius Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mobius Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Mobius Therapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Mobius Therapeutics is spiking on competitors!
Mobius Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Mobius Therapeutics
Check if Mobius Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Mobius Therapeutics launches new products
Funding: Get notified immidiatlly once Mobius Therapeutics has new funding data
Click to see if Mobius Therapeutics had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Mobius Therapeutics
Compare insights from companies similar to Mobius Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Mobius Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Mobius Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Mobius Therapeutics.
Mobius Therapeutics financials insights
Gather financial insights about Mobius Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2007
Series A
$3.5M
2010
Private Equity
$666K
2012
Private Equity
$1.7M
2013
Series B
$3M
2020
Debt
$150K
Mobius Therapeutics Tech Stack
A closer look at the technologies used by Mobius Therapeutics
See more technologies
Most Recent Scoops
Project
, according to a high-level source in marketing, is planning to leverage AI-driven analytic insights (e.g., predictive, strategic, etc.) over the next six to twelve months.
Artificial Intelligence
Project
, according to a high-level source in marketing, is planning upcoming initiatives related to automation / AI for marketing, campaign, and lead management.
Automation, Lead Management, Artificial Intelligence
Project
, according to a high-level source in marketing, is planning upcoming initiatives related to mobile and web analytics.
Mobility, Analytics & Insights, Website, Mobile Applications
Project
, according to a high-level source in marketing, is planning upcoming initiatives related to dashboards and data visualization.
Business Intelligence, Database, Analytics & Insights, Data Management, Data Science, Design & Graphics, Mapping & GIS
Project
Relationship Marketing, Marketing Strategy
Mobius Therapeutics News & Media
Mobius Therapeutics™ Customers to Advocate Use of Mitosol®
First use of social media platform by Mobius™ supports value proposition to end users. ST. LOUIS, May 10, 2022 /PRNewswire/ -- Mobius Therapeutics™, LLC, a St. Louis-based perioperative ophthalmic pharmaceutical company, will initiate a social media presence featuring interviews and live...Mobius Therapeutics™ Expands Professional Education and Support Activities
ST. LOUIS, June 30, 2020 /PRNewswire/ -- Recognizing the effect that COVID-19 has had on the routine of its customer base, Mobius Therapeutics™, LLC, the St. Louis-based makers of Mitosol® (mitomycin for solution) Kit for Ophthalmic Use, is renewing efforts and reassigning resources to...Mobius Therapeutics™ Continues Production and Distribution of Mitosol®
ST. LOUIS, April 7, 2020 /PRNewswire/ -- Mobius Therapeutics™, LLC, the St. Louis-based makers of Mitosol® (mitomycin for solution) 0.2 mg/vial Kit for Ophthalmic Use, has maintained production and inventory of Mitosol®, recognizing the non-elective nature of the patient population...Leiters and Mobius Therapeutics™ Enter into National Sales and Marketing Agreement for Mitosol®
DENVER, Colo. and ST. LOUIS, Feb. 14, 2019 /PRNewswire/ -- Leiters and Mobius Therapeutics announced today that they have entered into a national sales and marketing agreement for Mitosol®, the only FDA approved formulation of mitomycin-c bearing an ophthalmic indication. Leiters, a...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mobius Therapeutics
Sign Up For FreeTo access detailed company insights
Mobius Therapeutics is an FDA-approved pharmaceutical manufacturer focused on perioperative pharmaceuticals specifically for ophthalmology. The company aims to lead in this niche by identifying challenging needs and innovating solutions to enhance patient care, access, and provider safety. Their product offerings can be easily ordered through vario... Read More
